All Type of News
Health insurance benefit, another obstacle for Xeljanz to overcome
‘Xeljanz(generic name: tofacitinib),’ the world’s first oral rheumatoid arthritis treatment, has gotten over the wall of leading large hospitals in Korea.
However, due to the limitation in the health insurance benefi...
Listed pharmaceutical companies catches two hares, called sales and profits
It was observed listed pharmaceutical companies recorded decent operating performance in both sales and profitability in the last 3rd quarter.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of this ...
Hanmi’s legend of KRW 6 trillion technology export achieved by R&D
The reason why it was possible for Hanmi Pharm to export the new technology worth of KRW 6 trillion, which rarely happens even in the global market, was evaluated as its effort into endless investments in R&D.
While ...
Sales and profits of Hanmi and Huons fly in respective KOSPI and KOSDAQ
As a pharmaceutical company, Hanmi Pharm and Huons have made a rush in the KOSPI and KOSDAQ, respectively.
It was analyzed, particularly, 53 listed pharmaceutical companies recorded double-digit growth rates of avera...
Reverse argument by MSD Korea, “No way! Gardasil is much cost-effective”
Although same data was used to analyze cost effectiveness, a result was completely reversed.
On the 16th, MSD Korea announced an analysis result of comparing cases of vaccinating Gardasil, a cervical cancer vaccine, ...
KPIC’s program to collect patient information, ‘PM2000,’ is finally kicked out
‘PM2000,’ a program for pharmacies to claim dispensation of prescriptions, which became a route for the Korea Pharmaceutical Information Center(KPIC) to illegally collect patient information, will finally be eradicate...
Candidate companies to join in KRW 1 Trillion Sales ClubAfter Yuhan Corporation entered the KRW 1 trillion sales club for the first time in the pharmaceutical company last year, second and third candidate companies which may join in ...
|
48 lawsuits against Brilinta patent only in 15 days
Generics of Brilinta(AstraZeneca, ticagrelor), which has been recognized as a next-generation antithrombotic agent followed by Aspirin and Plavix, have attracted vigorous interests of domestic pharmaceutical companie...
3rd quarter’s decent performance of 41 listed pharmaceutical companies
Domestic pharmaceutical companies have made decent performance even in the MERS crisis.
According to the data aggregated from 41 listed pharmaceutical companies which published 3rd quarter’s tentative performance by ...
The largest therapeutic category was ‘Antipyretics & Analgesics’
It was observed antipyretic & analgesic drugs accounts for the highest portion of the total approved pharmaceutical products in Korea.
According to the therapeutic categories of 2014, approved by the Ministry of Food...
